| CAS ID: | 58166-24-8 |
| Molecular Formula: | C12H22O11 |
| Molecular Weight: | 342.3 g/mol |
| Monoisotopic Mass: | 342.1162 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | PORTALAC | CHOLAC | BIFITERAL | GENERLAC | E966 | CONSTILAC | OSMOLAX | LAXILOSE | DUPHALAC | CHRONULAC | HEPTALAC | EVALOSE | DUPHALAC DRY | CEPHULAC | REGULOSE | LEMLAX | ENULOSE | ACILAC | LACTULOSE | CONSTULOSE | LAXOSE ORANGE |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C12H22O11/c13-1-4-6(16)7(17)8(18)11(21-4)22-9-5(2-14)23-12(20,3-15)10(9)19/h4-11,13-20H,1-3H2/t4-,5-,6+,7+,8-,9-,10+,11+,12-/m1/s1 | See All |
| InChI Key: | JCQLYHFGKNRPGE-FCVZTGTOSA-N | |
| Smiles: | OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT01231828 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | November 1, 2010 | Last Verified | February 27, 2013 |
| Sponsor | University Hospital, Caen | ||
Trial Record 2
| ClinicalTrial ID | NCT02265484 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | October 16, 2014 | Last Verified | November 22, 2016 |
| Sponsor | Institute of Liver and Biliary Sciences, India | ||
Trial Record 3
| ClinicalTrial ID | NCT01842581 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | April 29, 2013 | Last Verified | April 27, 2017 |
| Sponsor | Valeant Pharmaceuticals International, Inc. | ||
Trial Record 4
| ClinicalTrial ID | NCT00748904 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Unknown |
| First Received | September 9, 2008 | Last Verified | January 4, 2011 |
| Sponsor | Weill Medical College of Cornell University | ||
Trial Record 5
| ClinicalTrial ID | NCT01923376 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Withdrawn |
| First Received | August 15, 2013 | Last Verified | May 12, 2015 |
| Sponsor | New York Methodist Hospital | ||
Trial Record 6
| ClinicalTrial ID | NCT03161106 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Withdrawn |
| First Received | May 19, 2017 | Last Verified | December 11, 2018 |
| Sponsor | Institute of Liver and Biliary Sciences, India | ||
Trial Record 7
| ClinicalTrial ID | NCT01283152 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | January 25, 2011 | Last Verified | December 11, 2014 |
| Sponsor | University of Texas Southwestern Medical Center | ||
Trial Record 8
| ClinicalTrial ID | NCT00004796 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | February 25, 2000 | Last Verified | June 24, 2005 |
| Sponsor | National Center for Research Resources (NCRR) | ||
| PubChem: | 11333 |
| ChEMBL: | CHEMBL296306 |